Research Articles
A Five-Year Victory: Powerful HIV Treatment Proves Its Mettle in Tough Cases
New five-year data confirms Bictegravir/Emtricitabine/Tenofovir Alafenamide effectively treats advanced HIV cases with high viral loads and low CD4 counts.
Fewer Pills, Same Power: The Real-World Success of the DTG+3TC HIV Regimen
Real-world evidence confirms DTG+3TC as an effective, tolerable HIV treatment with high virologic suppression rates and low resistance development.
HIV in 2010: The Year Treatment Became Prevention
Explore how potent antiretroviral drugs and sensitive assays transformed HIV treatment and monitoring in 2010, while significant challenges remained.
Fostemsavir: A Long-Acting Lifeline for Treatment-Experienced People with HIV
Explore how fostemsavir provides durable viral suppression and immune recovery for heavily treatment-experienced people with HIV through the BRIGHTE trial data.
A New Hope for Tough-to-Treat HIV: The Long-Term Power of Ibalizumab
Exploring the five-year success of ibalizumab for multidrug-resistant HIV patients, with data visualizations and clinical trial insights.
Revolutionizing HIV Treatment: How Same-Day Start Therapy is Changing Lives
Discover how Rapid Start Antiretroviral Therapy (RSA) is transforming HIV care by initiating treatment on the same day as diagnosis, dramatically accelerating viral suppression rates.
The Invisible Arms Race: Key Reports from the 2006 HIV Drug Resistance Workshop
Analysis of the XV International HIV Drug Resistance Workshop findings on HIV drug resistance patterns, transmission trends, and emerging treatments.